Answers are grounded in this paper and cite their sources.
Background/Objectives: Extracellular vesicles (EVs) from tumour cells mediate intercellular communication and contribute to chemoresistance by transferring functional cargo. However, their influence on hepatic drug metabolism during early chemotherapy adaptation remains unclear. Methods: EVs were isolated from doxorubicin (DOX)-sensitive parental (EVP) and DOX-adapted (EVA) MCF7 breast cancer (BC) spheroids and characterised for microRNA content. HepG2 hepatic spheroids were exposed to these EVs, and expression of 92 drug-metabolising enzyme (DME) genes was assessed by RT-qPCR. Pathway and enrichment analyses were performed to identify affected molecular networks. Results: EV-enriched fractions from DOX-adapted cells exhibited higher particle concentrations and distinct miRNA profiles compared to parental EV fractions. Exposure of hepatic spheroids to these EVs modulated gene expression related to xenobiotic, cholesterol and fatty acid metabolism. Conclusions: BC-derived EVs may modulate hepatic gene expression linked to drug response and metabolism, supporting the hypothesis that EV-mediated BC-liver communication may contribute to systemic adaptation during chemotherapy.
No takes yet. Share an insight, caveat, or question.
Ramos et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: